Trial of a Treatment Algorithm for the Management of Crohn's Disease
NCT01030809 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 1999
Last updated 2014-03-20
Summary
Assess if the implementation of a treatment algorithm will improve the management of Crohn's disease (CD) in comparison to usual care based gastroenterology practices.
Conditions
Interventions
- OTHER
-
Treatment Algorithm for Crohn's Disease
Practitioners assigned to the intervention arm will be educated on the use of the treatment algorithm.
Sponsors & Collaborators
- collaborator INDUSTRY
-
University of Western Ontario, Canada
lead OTHER
Principal Investigators
-
Brian G Feagan, MD · Robarts Research Institute - University of Western Ontario
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2010-01-31
- Primary Completion
- 2013-09-30
- Completion
- 2013-12-31
Countries
- Canada
Study Locations
More Related Trials
-
TDM Guided Early Optimization of ADAL in Crohn's Disease
NCT03261102 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Efficacy and Safety of Two Treatment Algorithms in Adults With Moderate to Severe Crohn's Disease
NCT01235689 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating a Shared Decision Making Program for Crohn's Disease
NCT02084290 ·Status: COMPLETED ·Phase: NA
-
Study of Adalimumab Treatment for Induction and Maintenance of Clinical Remission in Subjects With Crohn's Disease
NCT00409617 ·Status: COMPLETED ·Phase: PHASE3
-
Impact of Exclusion Diet in Addition to Anti-TNF Therapy in Crohn's Disease and Ulcerative Colitis: a Prospective, Randomized, Double-arm, Open-label Study
NCT06896305 ·Status: RECRUITING ·Phase: NA
-
Assessment of Mucosal Activity to Improve the Prognosis of Patients With Crohn's Disease Treated With Immunosuppressants
NCT01562951 ·Status: TERMINATED ·Phase: PHASE3
-
Dose Ranging Study Comparing the Efficacy, Safety and Pharmacokinetics of Intravenous Infusions of ABT-874 vs Placebo in Subjects With Active Crohn's Disease
NCT00562887 ·Status: TERMINATED ·Phase: PHASE2
-
Medical Treatment Versus Surgery in Stricturing Small Bowel Crohn's Disease
NCT05584228 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Long-term Safety and Tolerability Study of Adalimumab in Subjects With Crohn's Disease
NCT00195715 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Treat to Target Versus Routine Care Maintenance Strategies in Crohn's Disease Patients Treated With Ustekinumab
NCT03107793 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Abatacept in Patients With Active Crohn's Disease
NCT00406653 ·Status: TERMINATED ·Phase: PHASE3
-
Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects With Crohn's Disease
NCT00077779 ·Status: COMPLETED ·Phase: PHASE3
-
Human Anti-TNF Monoclonal Antibody Adalimumab in Canadian Subjects With Moderate to Severe Crohn's Disease (ACCESS)
NCT00427921 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Factors and Mechanisms Influencing the Effects of Treatments in Crohn's Disease
NCT04135027 ·Status: UNKNOWN
-
Active Surgical Intervention on Crohn's Disease
NCT05523050 ·Status: UNKNOWN ·Phase: NA
-
Prevention of Postoperative Endoscopic Recurrence With Endoscopy-driven Versus Systematic Biological Therapy
NCT05169593 ·Status: RECRUITING ·Phase: PHASE4
-
Intermittent Caloric Restriction in Patients With Mild to Moderate Crohn's Disease
NCT05683730 ·Status: RECRUITING ·Phase: NA
-
Top Down Versus Step Up Strategies in Crohn's Disease
NCT00554710 ·Status: COMPLETED ·Phase: PHASE4
-
A follow-on Safety Study in Subjects With Crohn's Disease Who Have Previously Been Withdrawn From the Double-blind Study CDP870-031 [NCT00152490] or CDP870-032 [NCT00152425] Due to an Exacerbation of Crohn's Disease
NCT00160706 ·Status: COMPLETED ·Phase: PHASE3
-
Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease
NCT00105300 ·Status: COMPLETED ·Phase: PHASE3
-
Group ACT for CD Pain- a Feasibility Study
NCT05418062 ·Status: UNKNOWN ·Phase: NA
-
A Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease
NCT00055523 ·Status: COMPLETED ·Phase: PHASE2
-
Extension Study to Assess Long Term Safety in Children and Adolescents With Crohn's Disease Receiving Certolizumab Pegol
NCT01190410 ·Status: COMPLETED ·Phase: PHASE2
-
Impact of an Oligomeric Diet in Intestinal Absorption and Inflammatory Markers in Patients With Crohn Disease
NCT04305535 ·Status: UNKNOWN ·Phase: NA
-
A Study to Evaluate the Long-Term Efficacy, Safety, and Tolerability of Repeated Administration of Upadacitinib (ABT-494) in Participants With Crohn's Disease
NCT02782663 ·Status: COMPLETED ·Phase: PHASE2